Because the large majority of patients that undergo surgery will succumb to metastatic relapse [1, 2], FGFR4 inhibition before surgery could improve the potential for cure with resection by preventing recurrent metastatic tumors. The gene discussed is FGFR4; the disease is metastatic neoplasm.